UniProt ID | NUDC1_HUMAN | |
---|---|---|
UniProt AC | Q96RS6 | |
Protein Name | NudC domain-containing protein 1 | |
Gene Name | NUDCD1 {ECO:0000312|HGNC:HGNC:24306} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 583 | |
Subcellular Localization |
Isoform 1: Cytoplasm. Nucleus. Isoform 2: Cytoplasm. Isoform 3: Cytoplasm. Nucleus. |
|
Protein Description | ||
Protein Sequence | MEVAANCSLRVKRPLLDPRFEGYKLSLEPLPCYQLELDAAVAEVKLRDDQYTLEHMHAFGMYNYLHCDSWYQDSVYYIDTLGRIMNLTVMLDTALGKPREVFRLPTDLTACDNRLCASIHFSSSTWVTLSDGTGRLYVIGTGERGNSASEKWEIMFNEELGDPFIIIHSISLLNAEEHSIATLLLRIEKEELDMKGSGFYVSLEWVTISKKNQDNKKYEIIKRDILRGKSVPHYAAIEPDGNGLMIVSYKSLTFVQAGQDLEENMDEDISEKIKEPLYYWQQTEDDLTVTIRLPEDSTKEDIQIQFLPDHINIVLKDHQFLEGKLYSSIDHESSTWIIKESNSLEISLIKKNEGLTWPELVIGDKQGELIRDSAQCAAIAERLMHLTSEELNPNPDKEKPPCNAQELEECDIFFEESSSLCRFDGNTLKTTHVVNLGSNQYLFSVIVDPKEMPCFCLRHDVDALLWQPHSSKQDDMWEHIATFNALGYVQASKRDKKFFACAPNYSYAALCECLRRVFIYRQPAPMSTVLYNRKEGRQVGQVAKQQVASLETNDPILGFQATNERLFVLTTKNLFLIKVNTEN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEVAANCS -------CCEECCCE | 9.37 | - | |
1 | Sulfoxidation | -------MEVAANCS -------CCEECCCE | 9.37 | 28465586 | |
3 (in isoform 2) | Phosphorylation | - | 6.18 | 26503514 | |
8 | Phosphorylation | MEVAANCSLRVKRPL CCEECCCEEEECCCC | 21.01 | 30108239 | |
8 (in isoform 2) | Phosphorylation | - | 21.01 | 26503514 | |
68 (in isoform 2) | Ubiquitination | - | 31.30 | 21906983 | |
88 | Phosphorylation | LGRIMNLTVMLDTAL HHHHHCHHHHHHHHC | 10.00 | 20068231 | |
93 | Phosphorylation | NLTVMLDTALGKPRE CHHHHHHHHCCCCCE | 21.59 | 20068231 | |
97 (in isoform 1) | Ubiquitination | - | 41.57 | 21906983 | |
97 | Ubiquitination | MLDTALGKPREVFRL HHHHHCCCCCEEECC | 41.57 | 2190698 | |
106 | Phosphorylation | REVFRLPTDLTACDN CEEECCCCCCCCCCC | 48.51 | 23403867 | |
109 | Phosphorylation | FRLPTDLTACDNRLC ECCCCCCCCCCCCEE | 28.22 | 23403867 | |
193 | Ubiquitination | RIEKEELDMKGSGFY HHHHHHHCCCCCEEE | 39.77 | 29967540 | |
222 | Ubiquitination | NKKYEIIKRDILRGK CCCEEEEEHHHHCCC | 50.07 | 29967540 | |
229 | Ubiquitination | KRDILRGKSVPHYAA EHHHHCCCCCCEEEE | 41.67 | - | |
251 | Phosphorylation | LMIVSYKSLTFVQAG EEEEEEEEEEEEECC | 25.14 | 27251275 | |
253 | Phosphorylation | IVSYKSLTFVQAGQD EEEEEEEEEEECCCC | 28.93 | 27251275 | |
270 | Phosphorylation | ENMDEDISEKIKEPL HCCCCCHHHHHHCCC | 45.20 | 25159151 | |
290 | Phosphorylation | TEDDLTVTIRLPEDS CCCCEEEEEECCCCC | 8.64 | 24719451 | |
321 | Ubiquitination | VLKDHQFLEGKLYSS EECCCHHHCCEEEEE | 7.35 | 29967540 | |
322 | Ubiquitination | LKDHQFLEGKLYSSI ECCCHHHCCEEEEEC | 56.42 | 29967540 | |
327 | Phosphorylation | FLEGKLYSSIDHESS HHCCEEEEECCCCCC | 31.11 | 28348404 | |
328 | Phosphorylation | LEGKLYSSIDHESST HCCEEEEECCCCCCE | 20.62 | 28348404 | |
336 | Ubiquitination | IDHESSTWIIKESNS CCCCCCEEEEEECCC | 7.70 | 29967540 | |
347 | Phosphorylation | ESNSLEISLIKKNEG ECCCEEEEEEECCCC | 18.05 | 24719451 | |
350 | Ubiquitination | SLEISLIKKNEGLTW CEEEEEEECCCCCCC | 55.64 | 29967540 | |
351 | Ubiquitination | LEISLIKKNEGLTWP EEEEEEECCCCCCCC | 53.92 | 29967540 | |
356 | Phosphorylation | IKKNEGLTWPELVIG EECCCCCCCCEEEEE | 50.24 | 30576142 | |
365 | Ubiquitination | PELVIGDKQGELIRD CEEEEECCCCCCHHH | 55.80 | 29967540 | |
373 | Phosphorylation | QGELIRDSAQCAAIA CCCCHHHHHHHHHHH | 15.47 | 26462736 | |
387 | Phosphorylation | AERLMHLTSEELNPN HHHHHHHCHHHHCCC | 21.29 | 25159151 | |
388 | Phosphorylation | ERLMHLTSEELNPNP HHHHHHCHHHHCCCC | 35.12 | 11416219 | |
430 | Phosphorylation | FDGNTLKTTHVVNLG ECCCEEEEEEEEECC | 25.83 | 24719451 | |
431 | Phosphorylation | DGNTLKTTHVVNLGS CCCEEEEEEEEECCC | 15.87 | 24719451 | |
438 | Phosphorylation | THVVNLGSNQYLFSV EEEEECCCCCEEEEE | 24.75 | 28348404 | |
444 | Phosphorylation | GSNQYLFSVIVDPKE CCCCEEEEEEECCCC | 14.35 | 24719451 | |
496 | Acetylation | VQASKRDKKFFACAP EECCCCCCCEEEECC | 56.35 | 25953088 | |
515 | Ubiquitination | AALCECLRRVFIYRQ HHHHHHHHHHHHCCC | 44.36 | 29967540 | |
544 | Ubiquitination | RQVGQVAKQQVASLE CCHHHHHHHHHHCCC | 42.27 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NUDC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUDC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUDC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PDC10_HUMAN | PDCD10 | physical | 22863883 | |
PLD3_HUMAN | PLD3 | physical | 22863883 | |
TYPH_HUMAN | TYMP | physical | 22863883 | |
UBA5_HUMAN | UBA5 | physical | 22863883 | |
DHX8_HUMAN | DHX8 | physical | 25036637 | |
PRP16_HUMAN | DHX38 | physical | 25036637 | |
DHX16_HUMAN | DHX16 | physical | 25036637 | |
COPB_HUMAN | COPB1 | physical | 25036637 | |
COPG2_HUMAN | COPG2 | physical | 25036637 | |
DHX40_HUMAN | DHX40 | physical | 25036637 | |
COPD_HUMAN | ARCN1 | physical | 25036637 | |
DHX33_HUMAN | DHX33 | physical | 25036637 | |
COPZ1_HUMAN | COPZ1 | physical | 25036637 | |
GLCM_HUMAN | GBA | physical | 25036637 | |
COPE_HUMAN | COPE | physical | 25036637 | |
FUCM_HUMAN | FUOM | physical | 25036637 | |
COPA_HUMAN | COPA | physical | 25036637 | |
COPB2_HUMAN | COPB2 | physical | 25036637 | |
COPG1_HUMAN | COPG1 | physical | 25036637 | |
DHX15_HUMAN | DHX15 | physical | 25036637 | |
DNHD1_HUMAN | DNHD1 | physical | 25036637 | |
VWA8_HUMAN | VWA8 | physical | 25036637 | |
NPT2B_HUMAN | SLC34A2 | physical | 25036637 | |
ERBB4_HUMAN | ERBB4 | physical | 25036637 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |